These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. A basic peptide derived from the HARP C-terminus inhibits anchorage-independent growth of DU145 prostate cancer cells. Bermek O; Diamantopoulou Z; Polykratis A; Dos Santos C; Hamma-Kourbali Y; Burlina F; Delbé J; Chassaing G; Fernig DG; Katsoris P; Courty J Exp Cell Res; 2007 Nov; 313(19):4041-50. PubMed ID: 17727841 [TBL] [Abstract][Full Text] [Related]
6. A Pleiotrophin C-terminus peptide induces anti-cancer effects through RPTPβ/ζ. Diamantopoulou Z; Bermek O; Polykratis A; Hamma-Kourbali Y; Delbé J; Courty J; Katsoris P Mol Cancer; 2010 Aug; 9():224. PubMed ID: 20738847 [TBL] [Abstract][Full Text] [Related]
7. Characterization of heparin affin regulatory peptide signaling in human endothelial cells. Polykratis A; Katsoris P; Courty J; Papadimitriou E J Biol Chem; 2005 Jun; 280(23):22454-61. PubMed ID: 15797857 [TBL] [Abstract][Full Text] [Related]
8. Proliferation and migration activities of fibroblast growth factor-2 in endothelial cells are modulated by its direct interaction with heparin affin regulatory peptide. Dos Santos C; Blanc C; Elahouel R; Prescott M; Carpentier G; Ori A; Courty J; Hamma-Kourbali Y; Fernig DG; Delbé J Biochimie; 2014 Dec; 107 Pt B():350-7. PubMed ID: 25315978 [TBL] [Abstract][Full Text] [Related]
9. Heparin affin regulatory peptide is a key player in prostate cancer cell growth and angiogenicity. Hatziapostolou M; Delbe J; Katsoris P; Polytarchou C; Courty J; Papadimitriou E Prostate; 2005 Oct; 65(2):151-8. PubMed ID: 15924335 [TBL] [Abstract][Full Text] [Related]
10. Mitogenic and in vitro angiogenic activity of human recombinant heparin affin regulatory peptide. Laaroubi K; Delbé J; Vacherot F; Desgranges P; Tardieu M; Jaye M; Barritault D; Courty J Growth Factors; 1994; 10(2):89-98. PubMed ID: 7520717 [TBL] [Abstract][Full Text] [Related]
11. Identification of heparin affin regulatory peptide domains with potential role on angiogenesis. Polykratis A; Delbé J; Courty J; Papadimitriou E; Katsoris P Int J Biochem Cell Biol; 2004 Oct; 36(10):1954-66. PubMed ID: 15203110 [TBL] [Abstract][Full Text] [Related]
15. The lysine-rich C-terminal tail of heparin affin regulatory peptide is required for mitogenic and tumor formation activities. Bernard-Pierrot I; Delbe J; Caruelle D; Barritault D; Courty J; Milhiet PE J Biol Chem; 2001 Apr; 276(15):12228-34. PubMed ID: 11150308 [TBL] [Abstract][Full Text] [Related]
16. A peptide corresponding to the C-terminal region of pleiotrophin inhibits angiogenesis in vivo and in vitro. Mikelis C; Lamprou M; Koutsioumpa M; Koutsioubas AG; Spyranti Z; Zompra AA; Spiliopoulos N; Vradis AA; Katsoris P; Spyroulias GA; Cordopatis P; Courty J; Papadimitriou E J Cell Biochem; 2011 Jun; 112(6):1532-43. PubMed ID: 21344482 [TBL] [Abstract][Full Text] [Related]
17. HARP induces angiogenesis in vivo and in vitro: implication of N or C terminal peptides. Papadimitriou E; Polykratis A; Courty J; Koolwijk P; Heroult M; Katsoris P Biochem Biophys Res Commun; 2001 Mar; 282(1):306-13. PubMed ID: 11264008 [TBL] [Abstract][Full Text] [Related]
18. Terrestrosin D, a steroidal saponin from Tribulus terrestris L., inhibits growth and angiogenesis of human prostate cancer in vitro and in vivo. Wei S; Fukuhara H; Chen G; Kawada C; Kurabayashi A; Furihata M; Inoue K; Shuin T Pathobiology; 2014; 81(3):123-32. PubMed ID: 24642631 [TBL] [Abstract][Full Text] [Related]